Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11234 Anderson St
B158
Loma Linda, CA 92354- Is this information wrong?
Education & Training
University of ColoradoFellowship, Gastroenterology, 2021 - 2024
University of ChicagoResidency, Internal Medicine, 2018 - 2021
University of Virginia School of MedicineClass of 2018, MD
University of TorontoMS, Nutritional Sciences , 2012 - 2014- University of TorontoBS, Nutritional Science , 2008 - 2012
Awards, Honors, & Recognition
- Poster of Distinction DDW, 2020
- Oral Presentation DDW, 2019
- Presidential Poster Award ACG, 2018
Publications & Presentations
PubMed
- 54 citationsRapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion.Jingzhou Wang, Arvin Bhatia, Noa Krugliak Cleveland, Nina Gupta, Sushila Dalal
ACG Case Reports Journal. 2018-08-01 - 79 citationsCOVID-19 reinfection: a rapid systematic review of case reports and case series.Jingzhou Wang, Christopher Kaperak, Toshiro Sato, Atsushi Sakuraba
Journal of Investigative Medicine. 2021-05-18 - 8 citationsWorldwide association of lifestyle-related factors and COVID-19 mortality.Jingzhou Wang, Toshiro Sato, Atsushi Sakuraba
Annals of Medicine. 2021-08-26
Journal Articles
- Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab ReintroductionInessa Normatov, MD, Daniela Fluxa, MD, Jingzhou D Wang, MD, Jacob E Ollech, MD, George E Gulotta, MS, Shivani Patel, PharmD, Maria A Quintero, MPH, Bety De la To..., Crohn's and Colitis 360, 7/13/2021
Abstracts/Posters
- RISK FACTORS AND TREATMENT OUTCOMES OF PERISTOMAL PYODERMA GANGRENOSUM IN INFLAMMATORY BOWEL DISEASEJingzhou Wang, Joshua C. Prenner, Wenfei Wang, Atsushi Sakuraba, Neil Hyman, Sushila Dalal, Roger D. Hurst, Russell D. Cohen, Konstantin Umanskiy, Benjamin D. Shogan, ..., DDW, Chicago IL, 5/4/2020
- Aseptic Meningitis With Multifocal White Matter T2 Hyperintensity In A Patient With Ulcerative Colitis On Vedolizumab: A Case ReportJingzhou Wang, Anthony Kanelidis, Joel Pekow, Shannon Martin, Advances in IBD, Orlando FL, 12/14/2019
- META-ANALYSIS: THE RISK OF DEVELOPING NEW ONSET INFLAMMATORY BOWEL DISEASE WITH INTERLEUKIN-17 BLOCKADE THERAPYDennis Jingzhou Wang, Akihiro Yamada, Yuga Komaki, Fukiko Komaki, Dejan Micic, Atsushi Sakuraba, DDW, San Diego, 5/21/2019
- Join now to see all
Press Mentions
P2221 - Polypharmacy May Represent an Independent Risk Factor of Disease Flare in Patients with Ulcerative ColitisOctober 9th, 2018
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin), Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
